Next Post

Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology

Natural Killer Cell Therapeutics in Oncology : Sanofi and Innate Pharma SA today announced the expansion of their partnership, with Sanofi licencing an NK cell engager programme from Innate’s ANKETTM (Antibody-based NK Cell Engager Therapeutics) technology that targets B7H3. Additionally, Sanofi will have the choice to add up to two […]
Oncology